Transcat - TRNS Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Transcat in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TRNS shares.
View TRNS analyst ratings or view top-rated stocks.

4 equities research analysts have issued 12-month price objectives for Transcat's shares. Their TRNS share price forecasts range from $92.00 to $100.00. On average, they expect the company's stock price to reach $95.50 in the next twelve months. This suggests a possible upside of 6.8% from the stock's current price.
View analysts price targets for TRNS or view top-rated stocks among Wall Street analysts.

Transcat's stock was trading at $70.87 on January 1st, 2023. Since then, TRNS shares have increased by 26.1% and is now trading at $89.39.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 22nd 2023.
View our TRNS earnings forecast.

Transcat, Inc. (NASDAQ:TRNS) released its quarterly earnings results on Monday, January, 30th. The scientific and technical instruments company reported $0.21 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.21. The scientific and technical instruments company had revenue of $57.40 million for the quarter, compared to analysts' expectations of $56.62 million. Transcat had a net margin of 4.49% and a trailing twelve-month return on equity of 12.30%.

ETFs with the largest weight of Transcat (NASDAQ:TRNS) stock in their portfolio include Invesco DWA SmallCap Momentum ETF (DWAS), AdvisorShares Dorsey Wright Micro-Cap ETF (DWMC), SPDR SSGA US Small Cap Low Volatility Index ETF (SMLV).iShares Micro-Cap ETF (IWC),

20 employees have rated Transcat Chief Executive Officer Lee Rudow on Glassdoor.com. Lee Rudow has an approval rating of 69% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Transcat investors own include Altria Group (MO), AT&T (T), Allena Pharmaceuticals (ALNA), Actinium Pharmaceuticals (ATNM), British American Tobacco (BTI), CBL & Associates Properties (CBL), Walt Disney (DIS), Verizon Communications (VZ), Cisco Systems (CSCO) and

Transcat trades on the NASDAQ under the ticker symbol "TRNS."

Shares of TRNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TRNS stock can currently be purchased for approximately $89.39.

Transcat (NASDAQ:TRNS) has a market capitalization of $675.79 million and generates $204.96 million in revenue each year. The scientific and technical instruments company earns $11.38 million in net income (profit) each year or $1.32 on an earnings per share basis.

The company employs 765 workers across the globe.

Transcat's mailing address is 35 VANTAGE POINT DRIVE, ROCHESTER NY, 14624. The official website for the company is www.transcat.com. The scientific and technical instruments company can be reached via phone at (585) 352-7777, via email at mtschiderer@transcat.com, or via fax at 585-352-1486.